M. A. Abreo, N. H. Lin, D. S. Garvey, D. E. Gunn, A. M. Hettinger, J. T. Wasicak:Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.Journal of Medicinal Chemistry,16.2.1996, 39. vsk, nro 4, s. 817–825.PubMed:8632405doi:10.1021/jm9506884ISSN0022-2623Artikkelin verkkoversio.
S. Ikushima, I. Muramatsu, Y. Sakakibara, K. Yokotani, M. Fujiwara:The effects of d-nicotine and l-isomer on nicotinic receptors.The Journal of Pharmacology and Experimental Therapeutics,elokuu 1982, 222. vsk, nro 2, s. 463–470.PubMed:7097565ISSN0022-3565Artikkelin verkkoversio.
N. L. Benowitz, P. Jacob, R. T. Jones, J. Rosenberg:Interindividual variability in the metabolism and cardiovascular effects of nicotine in man.The Journal of Pharmacology and Experimental Therapeutics,toukokuu 1982, 221. vsk, nro 2, s. 368–372.PubMed:7077531ISSN0022-3565Artikkelin verkkoversio.
Posselt, W.; Reimann, L.:Chemische Untersuchung des Tabaks und Darstellung eines eigenthümlich wirksamen Prinzips dieser Pflanze, s. 138–161.C.F. Müller, 1828.Teoksen verkkoversioViitattu 10.3.2018.(saksaksi)
Posselt, W.; Reimann, L.:Chemische Untersuchung des Tabaks und Darstellung eines eigenthümlich wirksamen Prinzips dieser Pflanze.(Tupakan kemiallinen tutkimus ja tämän kasvin tunnusomaisesti aktiivisen ainesosan valmistus)Magazin für Pharmacie,1828, 6. vsk, nro 24, s. 138–161.Artikkelin verkkoversio.(saksaksi)
Louis-Bernard Guyton de Morveau, Joseph Louis Gay-Lussac, Franc ois Arago, Michel Euge ne Chevreul, E. leuthe re E. lie Nicolas Mascart, Marcellin Berthelot:Annales de chimie et de physique, s. 465–479. (Katso erityisesti s. 470. Melsenin antama empiirinen kaava on väärin, sillä tuolloin kemistit käyttivät hiilelle väärää atomimassaa 6 oikean 12 sijaan)Masson., 1843.Teoksen verkkoversioViitattu 10.3.2018.(ranskaksi)
Suzanne L. Dickson, Emil Egecioglu, Sara Landgren, Karolina P. Skibicka, Jörgen A. Engel, Elisabet Jerlhag:The role of the central ghrelin system in reward from food and chemical drugs.Molecular and Cellular Endocrinology,20.6.2011, 340. vsk, nro 1, s. 80–87.PubMed:21354264doi:10.1016/j.mce.2011.02.017ISSN1872-8057Artikkelin verkkoversio.
Jack E. Henningfield, Mitch Zeller:Nicotine psychopharmacology research contributions to United States and global tobacco regulation: a look back and a look forward.Psychopharmacology,1.2.2006, 184. vsk, nro 3–4, s. 286–291.doi:10.1007/s00213-006-0308-4ISSN0033-3158Artikkelin verkkoversio.
Maarten Gees, Yeranddy A. Alpizar, Tomas Luyten, Jan B. Parys, Bernd Nilius, Geert Bultynck:Differential effects of bitter compounds on the taste transduction channels TRPM5 and IP3 receptor type 3.Chemical Senses,toukokuu 2014, 39. vsk, nro 4, s. 295–311.PubMed:24452633doi:10.1093/chemse/bjt115ISSN1464-3553Artikkelin verkkoversio.
Robert West, Witold Zatonski, Magdalena Cedzynska, Dorota Lewandowska, Joanna Pazik, Paul Aveyard:Placebo-controlled trial of cytisine for smoking cessation.The New England Journal of Medicine,29.9.2011, 365. vsk, nro 13, s. 1193–1200.PubMed:21991893doi:10.1056/NEJMoa1102035ISSN1533-4406Artikkelin verkkoversio.
M. A. Abreo, N. H. Lin, D. S. Garvey, D. E. Gunn, A. M. Hettinger, J. T. Wasicak:Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.Journal of Medicinal Chemistry,16.2.1996, 39. vsk, nro 4, s. 817–825.PubMed:8632405doi:10.1021/jm9506884ISSN0022-2623Artikkelin verkkoversio.
A. B. Elgoyhen, D. E. Vetter, E. Katz, C. V. Rothlin, S. F. Heinemann, J. Boulter:alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells.Proceedings of the National Academy of Sciences of the United States of America,13.3.2001, 98. vsk, nro 6, s. 3501–3506.PubMed:11248107doi:10.1073/pnas.051622798ISSN0027-8424Artikkelin verkkoversio.
Noor Azuin Suliman, Che Norma Mat Taib, Mohamad Aris Mohd Moklas, Mohd Ilham Adenan, Mohamad Taufik Hidayat Baharuldin, Rusliza Basir:Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic.Evidence-based Complementary and Alternative Medicine: eCAM,2016, nro 2016.PubMed:27656235doi:10.1155/2016/4391375ISSN1741-427XArtikkelin verkkoversio.
Konstantinos E. Farsalinos, Riccardo Polosa:Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review.Therapeutic Advances in Drug Safety,huhtikuu 2014, 5. vsk, nro 2, s. 67–86.PubMed:25083263doi:10.1177/2042098614524430ISSN2042-0986Artikkelin verkkoversio.
Konstantinos E. Farsalinos, Kurt A. Kistler, Gene Gillman, Vassilis Voudris:Evaluation of Electronic Cigarette Liquids and Aerosol for the Presence of Selected Inhalation Toxins.Nicotine & Tobacco Research,1.2.2015, 17. vsk, nro 2, s. 168–174.doi:10.1093/ntr/ntu176ISSN1462-2203Artikkelin verkkoversio.
Joseph G. Allen, Skye S. Flanigan, Mallory LeBlanc, Jose Vallarino, Piers MacNaughton, James H. Stewart:Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin in a Sample of 51 Products, Including Fruit-, Candy-, and Cocktail-Flavored E-Cigarettes.Environmental Health Perspectives,2016, 124. vsk, nro 6.doi:10.1289/ehp.1510185Artikkelin verkkoversio.Viitattu 15.3.2018. Arkistoitu24.3.2018.
Jennifer E. Bruin, Hertzel C. Gerstein, Alison C. Holloway:Long-Term Consequences of Fetal and Neonatal Nicotine Exposure: A Critical Review.Toxicological Sciences,elokuu 2010, 116. vsk, nro 2, s. 364.PubMed:20363831doi:10.1093/toxsci/kfq103Artikkelin verkkoversio.
Hui Chen, Ross Vlahos, Steve Bozinovski, Jessica Jones, Gary P. Anderson, Margaret J. Morris:Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice.Neuropsychopharmacology,huhtikuu 2005, 30. vsk, nro 4, s. 713–719.PubMed:15508020doi:10.1038/sj.npp.1300597ISSN0893-133XArtikkelin verkkoversio.
J. Le Houezec:Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.The International Journal of Tuberculosis and Lung Disease,syyskuu 2003, 7. vsk, nro 9, s. 811–819.PubMed:12971663ISSN1027-3719Artikkelin verkkoversio.
Hui Chen, Ross Vlahos, Steve Bozinovski, Jessica Jones, Gary P. Anderson, Margaret J. Morris:Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice.Neuropsychopharmacology,huhtikuu 2005, 30. vsk, nro 4, s. 713–719.PubMed:15508020doi:10.1038/sj.npp.1300597ISSN0893-133XArtikkelin verkkoversio.
Robert West, Witold Zatonski, Magdalena Cedzynska, Dorota Lewandowska, Joanna Pazik, Paul Aveyard:Placebo-controlled trial of cytisine for smoking cessation.The New England Journal of Medicine,29.9.2011, 365. vsk, nro 13, s. 1193–1200.PubMed:21991893doi:10.1056/NEJMoa1102035ISSN1533-4406Artikkelin verkkoversio.
Suzanne L. Dickson, Emil Egecioglu, Sara Landgren, Karolina P. Skibicka, Jörgen A. Engel, Elisabet Jerlhag:The role of the central ghrelin system in reward from food and chemical drugs.Molecular and Cellular Endocrinology,20.6.2011, 340. vsk, nro 1, s. 80–87.PubMed:21354264doi:10.1016/j.mce.2011.02.017ISSN1872-8057Artikkelin verkkoversio.
Chunjian Li, Wan Teng, Qiumei Shi, Fusuo Zhang:Multiple Signals Regulate Nicotine Synthesis in Tobacco Plant.Plant Signaling & Behavior,2007, 2. vsk, nro 4, s. 280–281.PubMed:19704681ISSN1559-2316Artikkelin verkkoversio.
J. N. Langley:On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari.The Journal of Physiology,30.12.1905, 33. vsk, nro 4–5, s. 374–413.PubMed:16992819ISSN0022-3751Artikkelin verkkoversio.
Maarten Gees, Yeranddy A. Alpizar, Tomas Luyten, Jan B. Parys, Bernd Nilius, Geert Bultynck:Differential effects of bitter compounds on the taste transduction channels TRPM5 and IP3 receptor type 3.Chemical Senses,toukokuu 2014, 39. vsk, nro 4, s. 295–311.PubMed:24452633doi:10.1093/chemse/bjt115ISSN1464-3553Artikkelin verkkoversio.
A. Shimada, H. Iizuka, T. Kawaguchi, T. Yanagita:[Pharmacodynamic effects of d-nicotine--Comparison with l-nicotine].Folia Pharmacologica Japonica,heinäkuu 1984, 84. vsk, nro 1, s. 1–10.PubMed:6489864ISSN0015-5691
S. Ikushima, I. Muramatsu, Y. Sakakibara, K. Yokotani, M. Fujiwara:The effects of d-nicotine and l-isomer on nicotinic receptors.The Journal of Pharmacology and Experimental Therapeutics,elokuu 1982, 222. vsk, nro 2, s. 463–470.PubMed:7097565ISSN0022-3565Artikkelin verkkoversio.
Robert West, Witold Zatonski, Magdalena Cedzynska, Dorota Lewandowska, Joanna Pazik, Paul Aveyard:Placebo-controlled trial of cytisine for smoking cessation.The New England Journal of Medicine,29.9.2011, 365. vsk, nro 13, s. 1193–1200.PubMed:21991893doi:10.1056/NEJMoa1102035ISSN1533-4406Artikkelin verkkoversio.
M. A. Abreo, N. H. Lin, D. S. Garvey, D. E. Gunn, A. M. Hettinger, J. T. Wasicak:Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.Journal of Medicinal Chemistry,16.2.1996, 39. vsk, nro 4, s. 817–825.PubMed:8632405doi:10.1021/jm9506884ISSN0022-2623Artikkelin verkkoversio.
L. M. Houlihan, Y. Slater, D. L. Guerra, J. H. Peng, Y. P. Kuo, R. J. Lukas:Activity of cytisine and its brominated isosteres on recombinant human alpha7, alpha4beta2 and alpha4beta4 nicotinic acetylcholine receptors.Journal of Neurochemistry,syyskuu 2001, 78. vsk, nro 5, s. 1029–1043.PubMed:11553677ISSN0022-3042Artikkelin verkkoversio.
A. B. Elgoyhen, D. E. Vetter, E. Katz, C. V. Rothlin, S. F. Heinemann, J. Boulter:alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells.Proceedings of the National Academy of Sciences of the United States of America,13.3.2001, 98. vsk, nro 6, s. 3501–3506.PubMed:11248107doi:10.1073/pnas.051622798ISSN0027-8424Artikkelin verkkoversio.
Noor Azuin Suliman, Che Norma Mat Taib, Mohamad Aris Mohd Moklas, Mohd Ilham Adenan, Mohamad Taufik Hidayat Baharuldin, Rusliza Basir:Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic.Evidence-based Complementary and Alternative Medicine: eCAM,2016, nro 2016.PubMed:27656235doi:10.1155/2016/4391375ISSN1741-427XArtikkelin verkkoversio.
J. Rosenberg, N. L. Benowitz, P. Jacob, K. M. Wilson:Disposition kinetics and effects of intravenous nicotine.Clinical Pharmacology and Therapeutics,lokakuu 1980, 28. vsk, nro 4, s. 517–522.PubMed:7408411ISSN0009-9236Artikkelin verkkoversio.Viitattu 27.7.2018. Arkistoitu25.5.2021.
J. Le Houezec:Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.The International Journal of Tuberculosis and Lung Disease,syyskuu 2003, 7. vsk, nro 9, s. 811–819.PubMed:12971663ISSN1027-3719Artikkelin verkkoversio.
N. L. Benowitz, P. Jacob, R. T. Jones, J. Rosenberg:Interindividual variability in the metabolism and cardiovascular effects of nicotine in man.The Journal of Pharmacology and Experimental Therapeutics,toukokuu 1982, 221. vsk, nro 2, s. 368–372.PubMed:7077531ISSN0022-3565Artikkelin verkkoversio.
Konstantinos E. Farsalinos, Riccardo Polosa:Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review.Therapeutic Advances in Drug Safety,huhtikuu 2014, 5. vsk, nro 2, s. 67–86.PubMed:25083263doi:10.1177/2042098614524430ISSN2042-0986Artikkelin verkkoversio.
H. L. Waldum, O. G. Nilsen, T. Nilsen, H. Rørvik, V. Syversen, A. K. Sanvik:Long-term effects of inhaled nicotine.Life Sciences,1996, 58. vsk, nro 16, s. 1339–1346.PubMed:8614291ISSN0024-3205Artikkelin verkkoversio.
Jennifer E. Bruin, Hertzel C. Gerstein, Alison C. Holloway:Long-Term Consequences of Fetal and Neonatal Nicotine Exposure: A Critical Review.Toxicological Sciences,elokuu 2010, 116. vsk, nro 2, s. 364.PubMed:20363831doi:10.1093/toxsci/kfq103Artikkelin verkkoversio.
Hui Chen, Ross Vlahos, Steve Bozinovski, Jessica Jones, Gary P. Anderson, Margaret J. Morris:Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice.Neuropsychopharmacology,huhtikuu 2005, 30. vsk, nro 4, s. 713–719.PubMed:15508020doi:10.1038/sj.npp.1300597ISSN0893-133XArtikkelin verkkoversio.
Chunjian Li, Wan Teng, Qiumei Shi, Fusuo Zhang:Multiple Signals Regulate Nicotine Synthesis in Tobacco Plant.Plant Signaling & Behavior,2007, 2. vsk, nro 4, s. 280–281.PubMed:19704681ISSN1559-2316Artikkelin verkkoversio.
J. N. Langley:On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari.The Journal of Physiology,30.12.1905, 33. vsk, nro 4–5, s. 374–413.PubMed:16992819ISSN0022-3751Artikkelin verkkoversio.
A. B. Elgoyhen, D. E. Vetter, E. Katz, C. V. Rothlin, S. F. Heinemann, J. Boulter:alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells.Proceedings of the National Academy of Sciences of the United States of America,13.3.2001, 98. vsk, nro 6, s. 3501–3506.PubMed:11248107doi:10.1073/pnas.051622798ISSN0027-8424Artikkelin verkkoversio.
Noor Azuin Suliman, Che Norma Mat Taib, Mohamad Aris Mohd Moklas, Mohd Ilham Adenan, Mohamad Taufik Hidayat Baharuldin, Rusliza Basir:Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic.Evidence-based Complementary and Alternative Medicine: eCAM,2016, nro 2016.PubMed:27656235doi:10.1155/2016/4391375ISSN1741-427XArtikkelin verkkoversio.
Konstantinos E. Farsalinos, Riccardo Polosa:Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review.Therapeutic Advances in Drug Safety,huhtikuu 2014, 5. vsk, nro 2, s. 67–86.PubMed:25083263doi:10.1177/2042098614524430ISSN2042-0986Artikkelin verkkoversio.
National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health:The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General.Atlanta (GA):Centers for Disease Control and Prevention (US), 2014.Teoksen verkkoversioViitattu 15.3.2018.
Jennifer E. Bruin, Hertzel C. Gerstein, Alison C. Holloway:Long-Term Consequences of Fetal and Neonatal Nicotine Exposure: A Critical Review.Toxicological Sciences,elokuu 2010, 116. vsk, nro 2, s. 364.PubMed:20363831doi:10.1093/toxsci/kfq103Artikkelin verkkoversio.
Joseph G. Allen, Skye S. Flanigan, Mallory LeBlanc, Jose Vallarino, Piers MacNaughton, James H. Stewart:Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin in a Sample of 51 Products, Including Fruit-, Candy-, and Cocktail-Flavored E-Cigarettes.Environmental Health Perspectives,2016, 124. vsk, nro 6.doi:10.1289/ehp.1510185Artikkelin verkkoversio.Viitattu 15.3.2018. Arkistoitu24.3.2018.
Maarten Gees, Yeranddy A. Alpizar, Tomas Luyten, Jan B. Parys, Bernd Nilius, Geert Bultynck:Differential effects of bitter compounds on the taste transduction channels TRPM5 and IP3 receptor type 3.Chemical Senses,toukokuu 2014, 39. vsk, nro 4, s. 295–311.PubMed:24452633doi:10.1093/chemse/bjt115ISSN1464-3553Artikkelin verkkoversio.
Konstantinos E. Farsalinos, Kurt A. Kistler, Gene Gillman, Vassilis Voudris:Evaluation of Electronic Cigarette Liquids and Aerosol for the Presence of Selected Inhalation Toxins.Nicotine & Tobacco Research,1.2.2015, 17. vsk, nro 2, s. 168–174.doi:10.1093/ntr/ntu176ISSN1462-2203Artikkelin verkkoversio.
Suzanne L. Dickson, Emil Egecioglu, Sara Landgren, Karolina P. Skibicka, Jörgen A. Engel, Elisabet Jerlhag:The role of the central ghrelin system in reward from food and chemical drugs.Molecular and Cellular Endocrinology,20.6.2011, 340. vsk, nro 1, s. 80–87.PubMed:21354264doi:10.1016/j.mce.2011.02.017ISSN1872-8057Artikkelin verkkoversio.
H. L. Waldum, O. G. Nilsen, T. Nilsen, H. Rørvik, V. Syversen, A. K. Sanvik:Long-term effects of inhaled nicotine.Life Sciences,1996, 58. vsk, nro 16, s. 1339–1346.PubMed:8614291ISSN0024-3205Artikkelin verkkoversio.
Jack E. Henningfield, Mitch Zeller:Nicotine psychopharmacology research contributions to United States and global tobacco regulation: a look back and a look forward.Psychopharmacology,1.2.2006, 184. vsk, nro 3–4, s. 286–291.doi:10.1007/s00213-006-0308-4ISSN0033-3158Artikkelin verkkoversio.
J. Rosenberg, N. L. Benowitz, P. Jacob, K. M. Wilson:Disposition kinetics and effects of intravenous nicotine.Clinical Pharmacology and Therapeutics,lokakuu 1980, 28. vsk, nro 4, s. 517–522.PubMed:7408411ISSN0009-9236Artikkelin verkkoversio.Viitattu 27.7.2018. Arkistoitu25.5.2021.
Joseph G. Allen, Skye S. Flanigan, Mallory LeBlanc, Jose Vallarino, Piers MacNaughton, James H. Stewart:Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin in a Sample of 51 Products, Including Fruit-, Candy-, and Cocktail-Flavored E-Cigarettes.Environmental Health Perspectives,2016, 124. vsk, nro 6.doi:10.1289/ehp.1510185Artikkelin verkkoversio.Viitattu 15.3.2018. Arkistoitu24.3.2018.
L. M. Houlihan, Y. Slater, D. L. Guerra, J. H. Peng, Y. P. Kuo, R. J. Lukas:Activity of cytisine and its brominated isosteres on recombinant human alpha7, alpha4beta2 and alpha4beta4 nicotinic acetylcholine receptors.Journal of Neurochemistry,syyskuu 2001, 78. vsk, nro 5, s. 1029–1043.PubMed:11553677ISSN0022-3042Artikkelin verkkoversio.
ascpt.onlinelibrary.wiley.com
J. Rosenberg, N. L. Benowitz, P. Jacob, K. M. Wilson:Disposition kinetics and effects of intravenous nicotine.Clinical Pharmacology and Therapeutics,lokakuu 1980, 28. vsk, nro 4, s. 517–522.PubMed:7408411ISSN0009-9236Artikkelin verkkoversio.Viitattu 27.7.2018. Arkistoitu25.5.2021.
Suzanne L. Dickson, Emil Egecioglu, Sara Landgren, Karolina P. Skibicka, Jörgen A. Engel, Elisabet Jerlhag:The role of the central ghrelin system in reward from food and chemical drugs.Molecular and Cellular Endocrinology,20.6.2011, 340. vsk, nro 1, s. 80–87.PubMed:21354264doi:10.1016/j.mce.2011.02.017ISSN1872-8057Artikkelin verkkoversio.
J. N. Langley:On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari.The Journal of Physiology,30.12.1905, 33. vsk, nro 4–5, s. 374–413.PubMed:16992819ISSN0022-3751Artikkelin verkkoversio.
Jack E. Henningfield, Mitch Zeller:Nicotine psychopharmacology research contributions to United States and global tobacco regulation: a look back and a look forward.Psychopharmacology,1.2.2006, 184. vsk, nro 3–4, s. 286–291.doi:10.1007/s00213-006-0308-4ISSN0033-3158Artikkelin verkkoversio.
Maarten Gees, Yeranddy A. Alpizar, Tomas Luyten, Jan B. Parys, Bernd Nilius, Geert Bultynck:Differential effects of bitter compounds on the taste transduction channels TRPM5 and IP3 receptor type 3.Chemical Senses,toukokuu 2014, 39. vsk, nro 4, s. 295–311.PubMed:24452633doi:10.1093/chemse/bjt115ISSN1464-3553Artikkelin verkkoversio.
A. Shimada, H. Iizuka, T. Kawaguchi, T. Yanagita:[Pharmacodynamic effects of d-nicotine--Comparison with l-nicotine].Folia Pharmacologica Japonica,heinäkuu 1984, 84. vsk, nro 1, s. 1–10.PubMed:6489864ISSN0015-5691
S. Ikushima, I. Muramatsu, Y. Sakakibara, K. Yokotani, M. Fujiwara:The effects of d-nicotine and l-isomer on nicotinic receptors.The Journal of Pharmacology and Experimental Therapeutics,elokuu 1982, 222. vsk, nro 2, s. 463–470.PubMed:7097565ISSN0022-3565Artikkelin verkkoversio.
Robert West, Witold Zatonski, Magdalena Cedzynska, Dorota Lewandowska, Joanna Pazik, Paul Aveyard:Placebo-controlled trial of cytisine for smoking cessation.The New England Journal of Medicine,29.9.2011, 365. vsk, nro 13, s. 1193–1200.PubMed:21991893doi:10.1056/NEJMoa1102035ISSN1533-4406Artikkelin verkkoversio.
M. A. Abreo, N. H. Lin, D. S. Garvey, D. E. Gunn, A. M. Hettinger, J. T. Wasicak:Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.Journal of Medicinal Chemistry,16.2.1996, 39. vsk, nro 4, s. 817–825.PubMed:8632405doi:10.1021/jm9506884ISSN0022-2623Artikkelin verkkoversio.
L. M. Houlihan, Y. Slater, D. L. Guerra, J. H. Peng, Y. P. Kuo, R. J. Lukas:Activity of cytisine and its brominated isosteres on recombinant human alpha7, alpha4beta2 and alpha4beta4 nicotinic acetylcholine receptors.Journal of Neurochemistry,syyskuu 2001, 78. vsk, nro 5, s. 1029–1043.PubMed:11553677ISSN0022-3042Artikkelin verkkoversio.
A. B. Elgoyhen, D. E. Vetter, E. Katz, C. V. Rothlin, S. F. Heinemann, J. Boulter:alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells.Proceedings of the National Academy of Sciences of the United States of America,13.3.2001, 98. vsk, nro 6, s. 3501–3506.PubMed:11248107doi:10.1073/pnas.051622798ISSN0027-8424Artikkelin verkkoversio.
Noor Azuin Suliman, Che Norma Mat Taib, Mohamad Aris Mohd Moklas, Mohd Ilham Adenan, Mohamad Taufik Hidayat Baharuldin, Rusliza Basir:Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic.Evidence-based Complementary and Alternative Medicine: eCAM,2016, nro 2016.PubMed:27656235doi:10.1155/2016/4391375ISSN1741-427XArtikkelin verkkoversio.
J. Rosenberg, N. L. Benowitz, P. Jacob, K. M. Wilson:Disposition kinetics and effects of intravenous nicotine.Clinical Pharmacology and Therapeutics,lokakuu 1980, 28. vsk, nro 4, s. 517–522.PubMed:7408411ISSN0009-9236Artikkelin verkkoversio.Viitattu 27.7.2018. Arkistoitu25.5.2021.
J. Le Houezec:Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.The International Journal of Tuberculosis and Lung Disease,syyskuu 2003, 7. vsk, nro 9, s. 811–819.PubMed:12971663ISSN1027-3719Artikkelin verkkoversio.
N. L. Benowitz, P. Jacob, R. T. Jones, J. Rosenberg:Interindividual variability in the metabolism and cardiovascular effects of nicotine in man.The Journal of Pharmacology and Experimental Therapeutics,toukokuu 1982, 221. vsk, nro 2, s. 368–372.PubMed:7077531ISSN0022-3565Artikkelin verkkoversio.
Konstantinos E. Farsalinos, Riccardo Polosa:Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review.Therapeutic Advances in Drug Safety,huhtikuu 2014, 5. vsk, nro 2, s. 67–86.PubMed:25083263doi:10.1177/2042098614524430ISSN2042-0986Artikkelin verkkoversio.
H. L. Waldum, O. G. Nilsen, T. Nilsen, H. Rørvik, V. Syversen, A. K. Sanvik:Long-term effects of inhaled nicotine.Life Sciences,1996, 58. vsk, nro 16, s. 1339–1346.PubMed:8614291ISSN0024-3205Artikkelin verkkoversio.
Konstantinos E. Farsalinos, Kurt A. Kistler, Gene Gillman, Vassilis Voudris:Evaluation of Electronic Cigarette Liquids and Aerosol for the Presence of Selected Inhalation Toxins.Nicotine & Tobacco Research,1.2.2015, 17. vsk, nro 2, s. 168–174.doi:10.1093/ntr/ntu176ISSN1462-2203Artikkelin verkkoversio.
Hui Chen, Ross Vlahos, Steve Bozinovski, Jessica Jones, Gary P. Anderson, Margaret J. Morris:Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice.Neuropsychopharmacology,huhtikuu 2005, 30. vsk, nro 4, s. 713–719.PubMed:15508020doi:10.1038/sj.npp.1300597ISSN0893-133XArtikkelin verkkoversio.